Cargando…

Reply to: Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation

The divergent views on lung cancer treatments in fibrosing lung patients reflect differences due to variable side-effect incidences in different countries and among ethnicities. International efforts are needed to better define treatment approaches. https://bit.ly/3DX40fq

Detalles Bibliográficos
Autores principales:	Funke-Chambour, Manuela, Kewalramani, Namrata, Machahua, Carlos, Poletti, Venerino, Wells, Athol U., Cadranel, Jacques
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835994/ https://www.ncbi.nlm.nih.gov/pubmed/36655227 http://dx.doi.org/10.1183/23120541.00469-2022

Ejemplares similares

Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges
por: Kewalramani, Namrata, et al.
Publicado: (2022)

Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation
por: Ishida, Yuriko, et al.
Publicado: (2022)

Dehydroepiandrosterone in fibrotic interstitial lung disease: a translational study
por: Guler, Sabina A., et al.
Publicado: (2022)

Comorbidities in interstitial lung diseases
por: Margaritopoulos, George A., et al.
Publicado: (2017)

Incidental discovery of interstitial lung disease: diagnostic approach, surveillance and perspectives
por: Tomassetti, Sara, et al.
Publicado: (2022)

Reply to comment on “The natural history of progressive fibrosing interstitial lung diseases”
por: Brown, Kevin K., et al.
Publicado: (2020)

Time to Trust Transbronchial Cryobiopsy in Identification of Usual Interstitial Pneumonia Pattern?
por: Poletti, Venerino, et al.
Publicado: (2021)

Before Freezing Out Cryobiopsy, We Need to Thaw Out Flaws in the Diagnosis of Interstitial Lung Disease
por: Maldonado, Fabien, et al.
Publicado: (2019)

Registries for Idiopathic Pulmonary Fibrosis: When Is It Time to Go Global?
por: Funke-Chambour, Manuela
Publicado: (2020)

Assembly 12: interstitial lung diseases
por: Antoniou, Katerina, et al.
Publicado: (2018)

Clinical implications of interstitial pneumonia with autoimmune features diagnostic criteria in idiopathic pulmonary fibrosis: A case control study
por: Tomassetti, Sara, et al.
Publicado: (2023)

Human-Based Advanced in vitro Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19
por: Kiener, Mirjam, et al.
Publicado: (2021)

Interstitial lung disease
por: Antoniou, Katerina M., et al.
Publicado: (2014)

Serum calprotectin as new biomarker for disease severity in idiopathic pulmonary fibrosis: a cross-sectional study in two independent cohorts
por: Machahua, Carlos, et al.
Publicado: (2021)

Bronchoalveolar lavage and lung biopsy in connective tissue diseases, to do or not to do?
por: Tomassetti, Sara, et al.
Publicado: (2021)

Post-COVID Interstitial Lung Disease—The Tip of the Iceberg
por: Kewalramani, Namrata, et al.
Publicado: (2023)

Interstitial Lung Abnormalities: An Evolving Entity
por: Tomassetti, Sara, et al.
Publicado: (2022)

Circulating calprotectin levels four months after severe and non-severe COVID-19
por: Abu Hussein, N., et al.
Publicado: (2023)

Interstitial pneumonia with autoimmune features: challenges and controversies
por: Mackintosh, John A., et al.
Publicado: (2021)

Interstitial lung diseases: course report
por: Kreuter, Michael, et al.
Publicado: (2019)

Choosing the appropriate pharmacotherapy for nonspecific chronic low back pain
por: Migliorini, Filippo, et al.
Publicado: (2022)

The role of precision medicine in interstitial lung disease
por: Maher, Toby M., et al.
Publicado: (2022)

Novel insights in cough and breathing patterns of patients with idiopathic pulmonary fibrosis performing repeated 24-hour-respiratory polygraphies
por: Schertel, Anke, et al.
Publicado: (2017)

Smoking and interstitial lung diseases
por: Margaritopoulos, George A., et al.
Publicado: (2015)

Comment on “Hyperglycemia in pregnancy: sleep alterations, comorbidities and pharmacotherapy”
por: Guo, Rui, et al.
Publicado: (2022)

MMP-7 and fcDNA Serum Levels in Early NSCLC and Idiopathic Interstitial Pneumonia: Preliminary Study
por: Ulivi, Paola, et al.
Publicado: (2013)

The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey: international survey and call for consensus
por: Tzouvelekis, Argyris, et al.
Publicado: (2021)

Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis – a potential biomarker role for LysoPC
por: Rindlisbacher, Barbara, et al.
Publicado: (2018)

Evolvement of best practice in diagnosis and management of idiopathic pulmonary fibrosis
por: Poletti, Venerino
Publicado: (2014)

Managing Lung Cancer with Comorbid Interstitial Pneumonia
por: Ichihara, Eiki, et al.
Publicado: (2019)

Introduction of cryobiopsies in the diagnostics of interstitial lung diseases – experiences in a referral center
por: Kronborg-White, Sissel, et al.
Publicado: (2017)

Reply to Althuwaybi et al.: Hospitalization Outcomes for COVID-19 in Patients with Interstitial Lung Disease: A Potential Role for Aerodigestive Pathophysiology?
por: Chaudhuri, Nazia, et al.
Publicado: (2021)

General principles of pharmacotherapy selection in elderly patients for different comorbidities
por: Stuhec, M.
Publicado: (2022)

Predictors of Appropriate Pharmacotherapy Management of COPD Exacerbations and Impact on 6-Month Readmission
por: Tran, Melody, et al.
Publicado: (2016)

Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Association With Initial Course of COVID-19
por: Diem, Lara, et al.
Publicado: (2022)

Non-specific interstitial pneumonia in cigarette smokers: a CT study
por: Marten, Katharina, et al.
Publicado: (2009)

Idiopathic pulmonary fibrosis: prognostic impact of histologic honeycombing in transbronchial lung cryobiopsy
por: Ravaglia, Claudia, et al.
Publicado: (2019)

Advances in epilepsy: new perspectives on new-onset epilepsy, comorbidities, and pharmacotherapy
por: Kanner, Andres M
Publicado: (2010)

Reply to: ‘NAFLD or comorbidities, that is the question’
por: Ji, Dong, et al.
Publicado: (2020)

Surgical Lung Biopsy and Cryobiopsy in Fibrosing Interstitial Lung Diseases: One Swallow Does Not Make a Summer
por: Bendstrup, Elisabeth, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cljgfth02l45do54pfmoqgj40n